Sulfonamides and derivatives thereof that modulate the activity of endothelin
AssigneeEncysive Pharmaceuticals, Inc.
InventorsChengde Wu, Natalie Blok, George W. Holland
Life of this patent
Estimating the term…
Loading patent…
AssigneeEncysive Pharmaceuticals, Inc.
InventorsChengde Wu, Natalie Blok, George W. Holland
Estimating the term…
Thienyl-, furyl-, pyrrolyl- and phenylsulfonamides, formulations of pharmaceutically-acceptable derivatives thereof and methods for modulating or altering the activity of the endothelin family of peptides are provided. In particular, N-(isoxazolyl)thienylsulfonamides, N-(isoxazolyl)furylsulfonamides, N-(isoxazolyl)pyrrolylsulfonamides and N-(isoxazolyl)phenylsulfonamides, formulations thereof and methods using these sulfonamides for inhibiting the binding of an endothelin peptide to an endothelin receptor by contacting the receptor with the sulfonamide are provided. Methods for treating endothelin-mediated disorders by administering effective amounts of one or more of these sulfonamides or pharmaceutically acceptable derivatives thereof that inhibit the activity of endothelin are also provided.
A compound that has formula IV:
A compound that has formula VII:
A compound that has formula X:
Dependencies are inferred from the claim text.